InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（23 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
23
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Robin Howard W, 董事长兼首席执行官. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 32 filings have been logged. Breakdown: 0 buy · 23 sells. Total volume traded: €1.1m. Activity tracked since 17 May 2021. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Robin Howard W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报32 总计
418 股@ US$71.98Common StockSEC:0001193125-26-359586:0
423 股@ US$73.002.9% 占其流量Common StockSEC:0001193125-26-061885:0
21,667 股0Common StockSEC:0001193125-25-331187:0
7,110 股0Common StockSEC:0001193125-25-297850:0
2,100 股@ US$45.169.1% 占其流量Common StockSEC:0000950170-25-114365:0
1,923 股@ US$32.3741.7% 占其流量Common StockSEC:0000950170-25-113691:0
1,500 股@ US$30.1652.0% 占其流量Common StockSEC:0000950170-25-113129:0
1,573 股@ US$26.59100.0% 占其流量Common StockSEC:0000950170-25-110773:0
23,208 股@ US$0.671.3% 占其流量Common StockSEC:0000950170-25-075976:0
23,774 股@ US$1.012.2% 占其流量Common StockSEC:0000950170-25-025035:0
46,995 股@ US$1.014.2% 占其流量Common StockSEC:0000950170-24-138693:0
410,625 股0Common StockSEC:0000950170-24-137543:0
16,278 股@ US$1.011.5% 占其流量Common StockSEC:0000950170-24-129461:0
14,881 股@ US$1.281.6% 占其流量Common StockSEC:0000950170-24-099352:0
16,650 股@ US$1.752.5% 占其流量Common StockSEC:0000950170-24-062646:0
20,033 股@ US$0.681.2% 占其流量Common StockSEC:0000950170-24-019043:0
19,877 股@ US$0.490.8% 占其流量Common StockSEC:0001209191-23-056182:0
19,998 股@ US$0.781.4% 占其流量Common StockSEC:0001209191-23-046460:0
20,361 股@ US$0.721.3% 占其流量Common StockSEC:0001209191-23-030446:0
19,635 股@ US$3.005.2% 占其流量Common StockSEC:0001209191-23-010952:0
38,014 股@ US$3.5712.3% 占其流量Common StockSEC:0001209191-22-057964:0
410,625 股0Common StockSEC:0001209191-22-046486:0
68,450 股0Common StockSEC:0001209191-22-029902:0
12,480 股@ US$10.956.1% 占其流量Common StockSEC:0001209191-22-011438:0
126,050 股0Common StockSEC:0001209191-21-070692:0
32 条申报中的 25 条
About Robin Howard W
ROBIN HOWARD W is Président-Directeur Général and is associated with NEKTAR THERAPEUTICS, where he is President & CEO. The declarant has 31 filings in total, and the 31 sampled filings, between 2016-01-21 and 2026-02-20, show only sales for a total of EUR 1,041,859.
